Location History:
- Gujarat, IN (2016 - 2017)
- Ahmedabad-Gujarat, IN (2017 - 2019)
Company Filing History:
Years Active: 2016-2019
Title: **The Innovations of Jayprakash Ajitsingh Parihar**
Introduction
Jayprakash Ajitsingh Parihar, an esteemed inventor based in Gujarat, India, has made significant contributions to the field of pharmaceuticals. With a total of 6 patents to his name, Parihar's work focuses on innovative processes that advance drug formulation and purity, primarily benefiting the treatment of diabetes and other medical conditions.
Latest Patents
Among his latest innovations, Parrhar holds a patent for the "Process for the Preparation of Brexpiprazole." This invention details a method to produce brexpiprazole with an impressive purity level of about 99.5% or more, ensuring that total impurities remain below 0.5%. The composition outlined in his patent includes brexpiprazole with minimal amounts of 1-(benzo[b]thiophen-4-yl)piperazine or its salts.
Additionally, Parihar has patented a "Process for the Preparation of Dapagliflozin." This innovation encompasses dapagliflozin compounds and methods of their preparation, as well as pharmaceutical compositions designed for diabetes treatment, showcasing his commitment to improving healthcare outcomes.
Career Highlights
Jayprakash Ajitsingh Parihar is affiliated with Cadila Healthcare Limited, a notable player in the pharmaceutical industry. His role there plays a critical part in the ongoing development and commercialization of cutting-edge pharmaceutical solutions. His patents underscore a career that merges creative scientific inquiry with practical applications in medicine.
Collaborations
Throughout his career, Parihar has collaborated with several talented professionals, including Shriprakash Dhar Dwivedi and Ashok Prasad. These partnerships reflect a collaborative spirit in innovation, as they work together to enhance the effectiveness and accessibility of medicinal products.
Conclusion
Jayprakash Ajitsingh Parihar's patents and collaborative efforts within the pharmaceutical field exemplify his dedication to advancing innovation in drug development. His contributions are not only a testament to his expertise but also support broader initiatives in improving health outcomes through innovative pharmaceuticals.